Outlook Therapeutics Inc (NASDAQ:OTLK)
| 1.17 BATS BZX Real-Time Price As of 12:10pm ET |  -0.025 / -2.10%Today’s Change | 0.68 Today|||52-Week Range 2.12 | +7.87% Year-to-Date |
Latest OTLK News | Press Releases
No recent news for Outlook Therapeutics Inc.
Today’s Trading
| Previous close | 1.19 |
| Today’s open | 1.19 |
| Day’s range | 1.16 - 1.19 |
| Volume | 2,015 |
| Average volume (3 months) | 492,636 |
| Market cap | $295.2M |
Data as of 12:10pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +10.57% |
| Earnings growth (this year) | +22.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 29.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RIGLRigel Pharmaceutical... | +0.07 | +4.24% |
| ---- | ||
| OCGNOcugen Inc | +0.00 | +0.38% |
| SELBSelecta Biosciences ... | -0.03 | -1.61% |
Data as of 12:36pm ET, 02/03/2023
Financials
| Next reporting date | February 15, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Iselin, New Jersey |
Forecasts
